Donnan Michael D, Scott Rizaldy P, Onay Tuncer, Tarjus Antoine, Onay Ummiye Venus, Quaggin Susan E
Division of Nephrology and Hypertension, Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Front Med (Lausanne). 2019 Aug 27;6:189. doi: 10.3389/fmed.2019.00189. eCollection 2019.
Nephrotic syndrome is one of the most common glomerular diseases in children and can be classified on the basis of steroid responsiveness. While multiple genetic causes have been discovered for steroid resistant nephrotic syndrome, the genetics of steroid sensitive nephrotic syndrome remains elusive. Mutations in Epithelial Membrane Protein 2 (), a member of the GAS3/PMP22 tetraspan family of proteins, were recently implicated as putative monogenic cause of steroid sensitive nephrotic syndrome. We investigated this hypothesis by developing reporter and knockout mouse models. In reporter mice (engineered to drive expression of the enzyme β-galactosidase under the control of the endogenous murine promoter), promoter activity was not observed in podocytes but was particularly prominent in medium- and large-caliber arterial vessels in the kidney and other tissues where it localizes specifically in vascular smooth muscle cells (vSMCs) but not in the endothelium. Strong expression was also found in non-vascular smooth muscle cells found in other organs like the stomach, bladder, and uterus. Global and podocyte-specific knockout mice were viable and did not develop nephrotic syndrome showing no evidence of abnormal glomerular histology or ultrastructure. Altogether, our results do not support that loss of function of represent a monogenic cause of proteinuric kidney disease. However, the expression pattern of indicates that it may be relevant in smooth muscle function in various organs and tissues including the vasculature.
肾病综合征是儿童最常见的肾小球疾病之一,可根据类固醇反应性进行分类。虽然已经发现了多种导致类固醇抵抗性肾病综合征的遗传原因,但类固醇敏感性肾病综合征的遗传学仍然不清楚。上皮膜蛋白2()是GAS3/PMP22四跨膜蛋白家族的成员,其突变最近被认为是类固醇敏感性肾病综合征的假定单基因病因。我们通过构建报告基因和基因敲除小鼠模型来研究这一假说。在报告基因小鼠(经工程改造以在内源性小鼠启动子的控制下驱动β-半乳糖苷酶的表达)中,在足细胞中未观察到启动子活性,但在肾脏和其他组织的中、大动脉血管中特别明显,在这些组织中它特异性地定位于血管平滑肌细胞(vSMC)而非内皮细胞。在胃、膀胱和子宫等其他器官的非血管平滑肌细胞中也发现了强烈的表达。全身性和足细胞特异性基因敲除小鼠是存活的,并且没有发展为肾病综合征,没有显示出肾小球组织学或超微结构异常的证据。总之,我们的结果不支持功能丧失代表蛋白尿性肾病的单基因病因。然而,的表达模式表明它可能与包括脉管系统在内的各种器官和组织中的平滑肌功能有关。